Deal History
About us
The Company
Team
Offices
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Healthcare
Software & TMT
Energy & Infrastructure
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
US
INT
DA
DE
FR
SV
Main menu button
Team
Deals
Contact
Team
Deals
Contact
News
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
All
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
All
05 Apr 2023
Mrkt BUZZ Zinzino: Important Central Europe continues to deliver
Equity Research
Zinzino
05 Apr 2023
Carlsquare weekly market letter: The worst may be over
Equity Research
Carlsquare
03 Apr 2023
Mrkt BUZZ ALM Equity: New owner in Klövern and upcoming new share issues
Equity Research
ALM Equity
01 Apr 2023
Research update Zazz Energy, Q4 2022: Possible upside in the stock, but significant risk
Equity Research
31 Mar 2023
First impression Zazz Energy, Q4 2022: Large write-downs and continued production standstill
Equity Research
30 Mar 2023
Mrkt BUZZ Risk Intelligence: The DHL deal, a great opportunity for upselling
Equity Research
Risk Intelligence
29 Mar 2023
Equity research Biosergen: Plans for speedy development of lead candidate
Equity Research
Biosergen
29 Mar 2023
Swedish Real Estate Equity Snapshot
Equity Research
29 Mar 2023
Carlsquare weekly market letter: Building energy, boiling and rotation beneath the surface
Equity Research
Carlsquare
22 Mar 2023
Carlsquare weekly market letter: Are we back to 1929 or 2008?
Equity Research
Carlsquare
20 Mar 2023
Initiation of coverage, Biosergen: Make antifungals great again
Equity Research
Biosergen
20 Mar 2023
Initiation of coverage Future Gaming: Reversed acquisition boosts Future Gaming
Equity Research
15 Mar 2023
Carlsquare weekly market letter: Tech rebounds as Fed trembles
Equity Research
Carlsquare
15 Mar 2023
Research Update Kancera, Q4 2022: Start of cancer trial expected shortly
Equity Research
13 Mar 2023
Research Update InCoax, Q4 2022: Positive follow-up orders from US operator
Equity Research
InCoax
10 Mar 2023
First Impression InCoax, Q4 2022: Better than expected revenues, but low gross margin
Equity Research
InCoax
08 Mar 2023
Carlsquare weekly market letter: Big Evening Star in S&P 500
Equity Research
Carlsquare
06 Mar 2023
Research update Zinzino, Q4 2022: Profit growth in the cards for 2023
Equity Research
Zinzino
06 Mar 2023
Research update Risk Intelligence, Q4 2022: Large global customers can give a boost
Equity Research
Risk Intelligence
01 Mar 2023
Carlsquare weekly market letter: Can Junk lead the way?
Equity Research
Carlsquare
1
…
25
26
27
28
29
…
64